These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17327420)

  • 21. Environmental contaminants activate human and polar bear (Ursus maritimus) pregnane X receptors (PXR, NR1I2) differently.
    Lille-Langøy R; Goldstone JV; Rusten M; Milnes MR; Male R; Stegeman JJ; Blumberg B; Goksøyr A
    Toxicol Appl Pharmacol; 2015 Apr; 284(1):54-64. PubMed ID: 25680588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The xenobiotic-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and orphan nuclear receptor hepatocyte nuclear factor 4alpha in the regulation of human steroid-/bile acid-sulfotransferase.
    Echchgadda I; Song CS; Oh T; Ahmed M; De La Cruz IJ; Chatterjee B
    Mol Endocrinol; 2007 Sep; 21(9):2099-111. PubMed ID: 17595319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors.
    Moore LB; Maglich JM; McKee DD; Wisely B; Willson TM; Kliewer SA; Lambert MH; Moore JT
    Mol Endocrinol; 2002 May; 16(5):977-86. PubMed ID: 11981033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing Adnectins that target SRC co-activator binding to PXR: a structural approach toward understanding promiscuity of PXR.
    Khan JA; Camac DM; Low S; Tebben AJ; Wensel DL; Wright MC; Su J; Jenny V; Gupta RD; Ruzanov M; Russo KA; Bell A; An Y; Bryson JW; Gao M; Gambhire P; Baldwin ET; Gardner D; Cavallaro CL; Duncia JV; Hynes J
    J Mol Biol; 2015 Feb; 427(4):924-942. PubMed ID: 25579995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges.
    Sepe V; D'Amore C; Ummarino R; Renga B; D'Auria MV; Novellino E; Sinisi A; Taglialatela-Scafati O; Nakao Y; Limongelli V; Zampella A; Fiorucci S
    Eur J Med Chem; 2014 Feb; 73():126-34. PubMed ID: 24388834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of PXR in drug metabolism: chemical and structural perspectives.
    Gee RRF; Huber AD; Chen T
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):9-23. PubMed ID: 38251638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of humanized steroid and xenobiotic receptor mouse by homologous knock-in of the human steroid and xenobiotic receptor ligand binding domain sequence.
    Igarashi K; Kitajima S; Aisaki K; Tanemura K; Taquahashi Y; Moriyama N; Ikeno E; Matsuda N; Saga Y; Blumberg B; Kanno J
    J Toxicol Sci; 2012; 37(2):373-80. PubMed ID: 22467028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A current structural perspective on PXR and CAR in drug metabolism.
    Buchman CD; Chai SC; Chen T
    Expert Opin Drug Metab Toxicol; 2018 Jun; 14(6):635-647. PubMed ID: 29757018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat pregnane X receptor: molecular cloning, tissue distribution, and xenobiotic regulation.
    Zhang H; LeCulyse E; Liu L; Hu M; Matoney L; Zhu W; Yan B
    Arch Biochem Biophys; 1999 Aug; 368(1):14-22. PubMed ID: 10415106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-angle X-ray scattering studies on structures of an estrogen-related receptor alpha ligand binding domain and its complexes with ligands and coactivators.
    Jin KS; Park JK; Yoon J; Rho Y; Kim JH; Kim EE; Ree M
    J Phys Chem B; 2008 Aug; 112(32):9603-12. PubMed ID: 18646811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel yeast-based strategy unveils antagonist binding regions on the nuclear xenobiotic receptor PXR.
    Li H; Redinbo MR; Venkatesh M; Ekins S; Chaudhry A; Bloch N; Negassa A; Mukherjee P; Kalpana G; Mani S
    J Biol Chem; 2013 May; 288(19):13655-68. PubMed ID: 23525103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnane X receptor: promiscuous regulator of detoxification pathways.
    Matic M; Mahns A; Tsoli M; Corradin A; Polly P; Robertson GR
    Int J Biochem Cell Biol; 2007; 39(3):478-83. PubMed ID: 17188925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR).
    Echchgadda I; Song CS; Oh TS; Cho SH; Rivera OJ; Chatterjee B
    Mech Ageing Dev; 2004; 125(10-11):733-45. PubMed ID: 15541768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of the conformational landscape in pregnane X receptor reveals a new binding pocket.
    Chandran A; Vishveshwara S
    Protein Sci; 2016 Nov; 25(11):1989-2005. PubMed ID: 27515410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pharmacophore for human pregnane X receptor ligands.
    Ekins S; Erickson JA
    Drug Metab Dispos; 2002 Jan; 30(1):96-9. PubMed ID: 11744617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands.
    Toell A; Kröncke KD; Kleinert H; Carlberg C
    J Cell Biochem; 2002; 85(1):72-82. PubMed ID: 11891851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput evaluation method for drug association with pregnane X receptor (PXR) using differential scanning fluorometry.
    Sekiguchi M; Kobashigawa Y; Moriguchi H; Kawasaki M; Yuda M; Teramura T; Inagaki F
    J Biomol Screen; 2013 Oct; 18(9):1084-91. PubMed ID: 23749765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol promotes intestinal cholesterol uptake mediated by Pregnane X receptor.
    Brown C; Kariuki W; Zhong HA; Kippes A; Sui Y
    Front Endocrinol (Lausanne); 2024; 15():1398462. PubMed ID: 38957441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural plasticity in the oestrogen receptor ligand-binding domain.
    Nettles KW; Bruning JB; Gil G; O'Neill EE; Nowak J; Guo Y; Kim Y; DeSombre ER; Dilis R; Hanson RN; Joachimiak A; Greene GL
    EMBO Rep; 2007 Jun; 8(6):563-8. PubMed ID: 17468738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of in vitro PXR-based assays and in silico modeling approaches for understanding the binding of a structurally diverse set of drugs to PXR.
    Xiao L; Nickbarg E; Wang W; Thomas A; Ziebell M; Prosise WW; Lesburg CA; Taremi SS; Gerlach VL; Le HV; Cheng KC
    Biochem Pharmacol; 2011 Mar; 81(5):669-79. PubMed ID: 21145880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.